NANAIMO AND MONTREAL, Feb. 14, 2018 /Weed Wire/ – Tilray, a global pioneer in cannabis cultivation, processing and distribution, announced today that it has signed a Letter of Intent (LOI) with Société des alcools du Québec (SAQ) to supply the province of Quebec with high-quality cannabis products in anticipation of adult-use legalization later this year.
Tag Archives: Tilray
Tilray Announces Completion of Series A Funding Round
TORONTO, Ontario, Feb. 8, 2018 /Weed Wire/ – Tilray, a global pioneer in medical cannabis research, cultivation, processing and distribution, today announced the completion of its Series A funding round totaling C$60 million. The round was comprised of a group of leading global institutional investors.
Privateer Holdings Closes $100+ Million Funding Round, Announces $5 Million Equity Pledge
SEATTLE, Jan. 25, 2018 /Weed Wire/ – Privateer Holdings, the world’s leading private equity firm investing exclusively in legal cannabis, today announced the completion of its Series C funding round and a pledge from the firm’s founders to donate equity equivalent to $5 million at the firm’s current valuation to help communities harmed by cannabis prohibition.
Portuguese Doctors Back Marijuana Medicine as Bill Enters Parliament
Portugal’s influential Doctors’ Association called for the legalization of marijuana-based medicines on Thursday, the same day parliament started to debate a draft bill that goes even further in seeking to allow patients to grow pot at home.
Tilray Receives Support For Medical Cannabis Innovation
NANAIMO, British Columbia, Nov. 30, 2017 /Weed Wire/ — We’re excited to announce that Tilray received research funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support product development and other research projects.
Tilray Exports Medical Cannabis Genetics to the European Union
NANAIMO, British Columbia, Nov. 8, 2017 /Weed Wire/ — Tilray, a GMP-certified global leader in medical cannabis research and production, today announced that the company has successfully exported live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal.
Tilray Exports Medical Cannabis Products to New Zealand for Nationwide Distribution
NANAIMO, British Columbia, Sept. 28, 2017 /Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today announced that Tilray medical cannabis products have been successfully exported to New Zealand and are now available for distribution nationwide.
Tilray to Supply EU Cannabis From Portugal
Canadian cannabis producer Tilray says it will invest 20 million euros in a medical cannabis operation in Portugal after winning federal licences there.
Tilray Receives License to Produce Medical Cannabis in the European Union
CANTANHEDE, Portugal, Sept. 7, 2017 /Weed Wire/ – Tilray, a global pioneer in medical cannabis research and production, announced plans today to invest up to €20 million in a European Union Campus (EU Campus) after receiving licenses from the Government of Portugal to import cannabis genetics and to cultivate cannabis for medical purposes.
Tilray Announces Second Facility Enabling 5x Increase in Production Capacity
NANAIMO, British Columbia, Aug. 17, 2017 /Weed Wire/ — Tilray Canada Ltd., a Good Manufacturing Practice (GMP)-certified global leader in medical cannabis research and production, announced today that it will invest, through an affiliated entity, up to $30 million in a second cultivation and processing facility located in Enniskillen, Ontario.
Tilray Announces Support for Clinical Trial Examining Cannabis and Chronic Lung Disease
NANAIMO, British Columbia, June 15, 2017 / Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today announced a partnership with the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, one of the world’s premier public academic and research institutions, to study the effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD).
Tilray Unveils New Product Categorization System in Canada
NANAIMO, British Columbia, May 15, 2017 /Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today unveiled a new product categorization system that simplifies the process of choosing medical cannabis products for patients in Canada.
Chile Starts Selling Cannabis Medicines at Some Pharmacies
Chile has become the first country in Latin America to sell cannabis medicines at pharmacies. The pilot program was launched Wednesday.
Tilray Announces Medical Cannabis Export to Cyprus
NANAIMO, British Columbia, May 4, 2017 /Weed Wire/ – Tilray, a global leader in medical cannabis research and production, today announced that Tilray cannabinoid products have arrived and are cleared for distribution in European Union member state Cyprus after the company received necessary approvals in Canada and Cyprus to export cannabinoid formulations for patients in Cyprus.
Study: Canadian Patients Substituting Marijuana for Prescription Drugs
According to a study recently published by the International Journal of Drug Policy, patients in Canada are substituting marijuana for opioids, benzodiazepines and antidepressants for symptom relief from pain and mental health conditions.
Tilray Announces Medical Cannabis Export to New Zealand
NANAIMO, British Columbia, Feb. 14, 2017 /Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today announced that it has received necessary approvals in Canada and New Zealand to export medical cannabis to New Zealand.
Tilray Announces Medical Cannabis Export to Chile
NANAIMO, British Columbia, Feb. 1, 2017 /Weed Wire/ —Tilray, a global leader in medical cannabis research and production, today announced that it has received necessary regulatory approvals in Canada and Chile to export medical cannabis for distribution to Chilean patients.
Kings of Cannabis Capital: Privateer First to Raise Over $100 Million
On Nov. 4, 2016, Privateer Holdings, a Seattle-based private equity firm focused on the legal cannabis industry, announced that it has closed $40 million in convertible bridge funding, the first part of a future $100 million Series C equity round.
Privateer Holdings Closes $40 Million in Convertible Note Financing
SEATTLE, Nov. 4, 2016 /Weed Wire/ — Privateer Holdings, the world’s first private equity firm to invest exclusively in legal cannabis, today announced that the company has closed an additional $40 million in convertible bridge financing.
Tilray Now Exporting Canadian Medical Cannabis Extracts to Croatia
Tilray, a licensed cannabis producer in Canada and owned by Seattle-based Privateer Holdings, became the first Canadian company licensed by the Canada’s Marihuana for Medical Purposes Regulations to legally export medical cannabis cultivated and processed in Canada.
CannMed 2016 Conference to Be Live Streamed Including the Keynote Speech by Noted Israeli Marijuana Research Pioneer Dr. Raphael Mechoulam
BOSTON, April 6, 2016 /Weed Wire/ — Medicinal Genomics and Courtagen Life Sciences today announced that the entire full day program of CannMed 2016 will be live streamed on Monday, April 11th, 2016.
CEO of Privateer Holdings: ‘Cannabis in the United States is Bigger than Corn’
On Dec. 4, 2015, Bloomberg’s Britton Staniar and Peter Robison interviewed Brendan Kennedy, CEO of Privateer Holdings, a private equity firm focused on the legal cannabis industry, in Seattle to discuss Privateer’s investments in cannabis-related businesses.
Tilray Medical Marijuana Company Lays Off 61 in Nanaimo
One of Vancouver Island’s largest medical marijuana growing companies announced Thursday it is laying off 61 employees.
Cannabis in Canada: A Data Snapshot
The evolution of the cannabis market in Canada continues to be a crucial case study. There is a lot we can learn about how business models are taking shape and the headwinds being faced in the legalized medical environment that the Canadian MMPR provides.